|
KPNA4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.32699999999542E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.35869999995375E-06 |
| Normal-vs-Stage2 |
1.214240E-02 |
| Normal-vs-Stage3 |
2.624400E-04 |
| Normal-vs-Stage4 |
9.97299999999646E-05 |
| Stage1-vs-Stage2 |
3.195200E-01 |
| Stage1-vs-Stage3 |
7.602000E-01 |
| Stage1-vs-Stage4 |
5.163400E-01 |
| Stage2-vs-Stage3 |
5.228600E-01 |
| Stage2-vs-Stage4 |
2.148600E-01 |
| Stage3-vs-Stage4 |
4.514000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.66879999999414E-06 |
| Normal-vs-AfricanAmerican |
5.373500E-02 |
| Normal-vs-Asian |
3.162300E-04 |
| Caucasian-vs-AfricanAmerican |
3.313000E-01 |
| Caucasian-vs-Asian |
7.790200E-01 |
| AfricanAmerican-vs-Asian |
2.615800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.80080000000383E-05 |
| Normal-vs-Female |
1.91459999998589E-06 |
| Male-vs-Female |
8.326600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.41959999999208E-05 |
| Normal-vs-Age(41-60Yrs) |
2.03119999997448E-06 |
| Normal-vs-Age(61-80Yrs) |
4.417800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.714400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.838200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.823400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.724600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.155800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.594400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.825800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.277800E-01 |
| Classical-VS-Follicular |
5.500200E-01 |
| Classical-VS-Other |
2.526600E-01 |
| Classical-VS-Normal |
2.33719999999105E-05 |
| Tall-VS-Follicular |
9.704400E-01 |
| Tall-VS-Other |
4.026400E-01 |
| Tall-VS-Normal |
6.682500E-03 |
| Follicular-VS-Other |
4.203200E-01 |
| Follicular-VS-Normal |
4.380200E-04 |
| Other-VS-Normal |
1.914050E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.37249999998534E-06 |
| Normal-vs-N1 |
5.79389999999513E-05 |
| N0-vs-N1 |
5.502400E-01 |
|
|
